38212-30-5 | 1-(4-methoxyphenyl)piperazine

Packsize	Purity	Availability	Price	Discounted Price
250mg	99%	in stock	$16.00	$11.00
1g	99%	in stock	$23.00	$16.00
5g	99%	in stock	$65.00	$45.00
25g	99%	in stock	$318.00	$222.00

Description

• Catalog Number: AB56631
• Chemical Name: 1-(4-methoxyphenyl)piperazine
• CAS Number: 38212-30-5
• Molecular Formula: C11H16N2O
• Molecular Weight: 192.2575
• MDL Number: MFCD00040736
• SMILES: COc1ccc(cc1)N1CCNCC1

Computed Properties

• Complexity: 161
• Covalently-Bonded Unit Count: 1
• Heavy Atom Count: 14
• Hydrogen Bond Acceptor Count: 3
• Hydrogen Bond Donor Count: 1
• Rotatable Bond Count: 2
• XLogP3: 1.2

Literature

• Hepatotoxicity of piperazine designer drugs: up-regulation of key enzymes of cholesterol and lipid biosynthesis.

  Archives of toxicology 20161201

• Structure-dependent inhibition of the human α1β2γ2 GABAA receptor by piperazine derivatives: A novel mode of action.

  Neurotoxicology 20151201

• Piperazine compounds as drugs of abuse.

  Drug and alcohol dependence 20120501

• Determination of piperazine-type stimulants in human urine by means of microextraction in packed sorbent and high performance liquid chromatography-diode array detection.

  Journal of pharmaceutical and biomedical analysis 20120305

• 10α-Hy-droxy-13-{[4-(4-meth-oxy-phen-yl)piperazin-1-yl]meth-yl}-4,9-dimethyl-3,8,15-trioxatetra-cyclo-[10.3.0.0.0]penta-decan-14-one.

  Acta crystallographica. Section E, Structure reports online 20120301

• Rapid determination of piperazine-type stimulants in human urine by microextraction in packed sorbent after method optimization using a multivariate approach.

  Journal of chromatography. A 20120127

• Analysis of phenylpiperazine-like stimulants in human hair as trimethylsilyl derivatives by gas chromatography-mass spectrometry.

  Journal of chromatography. A 20101001

• 4-(4-Methoxy-phen-yl)piperazin-1-ium chloride.

  Acta crystallographica. Section E, Structure reports online 20090301

• The effects of non-medically used psychoactive drugs on monoamine neurotransmission in rat brain.

  European journal of pharmacology 20070322

• Metabolism of designer drugs of abuse.

  Current drug metabolism 20050601

• In vivo metabolism of the new designer drug 1-(4-methoxyphenyl)piperazine (MeOPP) in rat and identification of the human cytochrome P450 enzymes responsible for the major metabolic step.

  Xenobiotica; the fate of foreign compounds in biological systems 20040201

• Toxicological detection of the new designer drug 1-(4-methoxyphenyl)piperazine and its metabolites in urine and differentiation from an intake of structurally related medicaments using gas chromatography-mass spectrometry.

  Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20031225

• Screening for and validated quantification of amphetamines and of amphetamine- and piperazine-derived designer drugs in human blood plasma by gas chromatography/mass spectrometry.

  Journal of mass spectrometry : JMS 20030601

• Piperazine-like compounds: a new group of designer drugs-of-abuse on the European market.

  Forensic science international 20010915